Foresite Capital Management Vi LLC Edgewise Therapeutics, Inc. Transaction History
Foresite Capital Management Vi LLC
- $183 Billion
- Q1 2025
A detailed history of Foresite Capital Management Vi LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 585,000 shares of EWTX stock, worth $7.68 Million. This represents 7.05% of its overall portfolio holdings.
Number of Shares
585,000
Previous 585,000
-0.0%
Holding current value
$7.68 Million
Previous $15.6 Billion
17.6%
% of portfolio
7.05%
Previous 6.96%
Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$197 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$117 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$85.9 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$80.8 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$78.9 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $829M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...